Sebobalance Spot Control
NDC Package 62499-384-11
Package Information
Sebobalance Spot Control is morning and evening, after a thorough cleansing of the skin, apply SeboBalance Spot ControlGel locally on cutanous imperfections. Marketed by Laboratoire Dr. Renaud, this product is identified by NDC 62499-384 and is authorized under FDA application part358H.
Identification & Billing
- RxCUI: 1020053 - SeboBalance Spot Control 1 % Topical Gel
- RxCUI: 1020053 - salicylic acid 0.01 MG/MG Topical Gel [Sebobalance]
- RxCUI: 1020053 - Sebobalance 0.01 MG/MG Topical Gel
- RxCUI: 1020053 - Sebobalance Spot Control 1 % Topical Gel
- RxCUI: 251380 - salicylic acid 1 % Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62499 - Laboratoire Dr. Renaud
- 62499-384 - Sebobalance Spot Control
- 62499-384-11 - 1 BOTTLE, WITH APPLICATOR in 1 CARTON / 8 g in 1 BOTTLE, WITH APPLICATOR (62499-384-07)
- 62499-384 - Sebobalance Spot Control
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62499-384-11 identifies a specific commercial package of 1 bottle, with applicator in 1 carton / 8 g in 1 bottle, with applicator (62499-384-07) of Sebobalance Spot Control, labeled by Laboratoire Dr. Renaud. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Laboratoire Dr. Renaud on June 30, 2010. The current certification is valid through December 31, 2017.
How is this Laboratoire Dr. Renaud product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62499038411. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.